Interestingly, a recent study shows that treatment with statins leads to a significantly greater inhibition of cell viability and expression of Wnt target in the APC mutant cell lines and patient-derived xenograft models as compared to wild-type APC cells, supporting the use of statins in APC-driven CRC (31). This evidence concerns the gene APC and colorectal carcinoma.